Identifying p53 Target Genes Using Hypomorphic Variants

Abstract

Summary:The reduced tumor suppression activity of hypomorphic variants of the TP53 gene was used by Indeglia and colleagues to corroborate PADI4 as a p53 target. The study makes a noteworthy advancement in comprehending the downstream implications of TP53–PDI4, including potential predictions of survival and the efficacy of immunotherapy.See related article by Indeglia et al., p. 1696 (4).